RECRUITINGOBSERVATIONAL

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

About This Trial

The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.

Who May Be Eligible (Plain English)

Who May Qualify: - Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis - Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring - Subjects who have other known liver diseases ie: HCV Who Should NOT Join This Trial: - Patients less than 18 years of age - Pregnancy - Patients that do not want to be contacted for consideration in future research studies. - Patients diagnosed with ascites or peritoneal dialysis - Body mass index (BMI) ≥40 Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Subjects with known, or suspected risk factors for steatosis (fat) or hepatic fibrosis * Subjects who have been previously diagnosed with Non-Alcoholic Steatohepatitis (NASH) but who do not have current steatosis (fat) or fibrosis scoring * Subjects who have other known liver diseases ie: HCV Exclusion Criteria: * Patients less than 18 years of age * Pregnancy * Patients that do not want to be contacted for consideration in future research studies. * Patients diagnosed with ascites or peritoneal dialysis * Body mass index (BMI) ≥40

Treatments Being Tested

PROCEDURE

vibration controlled transient elastography (VCTE)

Once on the examination table, the subject will be instructed to place the right arm under their head and to cross their right ankle over the left ankle. The subject will then be asked to slightly bend to the left side to open the intercostal space. Subsequently, a handheld probe is placed in the intercostal space overlaying the right hepatic lobe. The velocity of returning shear waves, measured at a depth of 25-65 mm, is converted into a liver stiffness measurement (LSM). The LSM obtained from a given VCTE exam is the median value of at least 10 successful measurements. This information, along with clinical data associated with the patient will be placed in a database for use in identifying potential subjects for future trials.

Locations (1)

Conventus Medical Office Building

Buffalo, New York, United States